[RGLS] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -53.87%
YoY- 63.78%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 6 18 18 18 6,778 18 18 -51.89%
PBT -5,945 -4,893 -5,423 -5,015 -3,260 -8,502 -10,273 -30.53%
Tax -8 -131 87 1 56 61 201 -
NP -5,937 -4,893 -5,423 -5,016 -3,260 -8,563 -10,273 -30.59%
Tax Rate - - - - - - - -
Total Cost 5,943 4,911 5,441 5,034 10,038 8,581 10,291 -30.62%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -98,950.00 -27,183.33 -30,127.78 -27,866.67 -48.10 -47,572.22 -57,072.22 44.27%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -2.47 -2.34 -2.60 -3.00 -3.14 -9.75 -11.80 -64.71%
EPS Diluted -2.47 -2.34 -2.60 -3.00 -3.14 -9.75 -11.80 -64.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.